2 chapters across the catalog
The hosts compare the current Ozempic craze to the 1990s Fen-Phen scandal, which resulted in massive lawsuits due to heart valve failure. They speculate that Pfizer's failure to produce a competing weight-loss drug may lead to increased regulatory and legal pressure on Novo Nordisk.
The hosts pay tribute to Kevin Samuels, a polarizing figure in independent media who recently passed away from a heart-related issue. They discuss his impact on the "Black Manosphere" and the importance of humanizing figures who offer alternative viewpoints outside of mainstream narratives. The segment notes the vitriolic reaction to his death on social media platforms like Black Twitter.
